enVVeno Medical Corp (NVNO)

Currency in USD
10.475
+0.145(+1.40%)
Real-time Data·
NVNO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.47510.700
52 wk Range
8.670179.550
Key Statistics
Prev. Close
10.6
Open
10.69
Day's Range
10.475-10.7
52 wk Range
8.67-179.55
Volume
2.88K
Average Volume (3m)
13.64K
1-Year Change
-93.8545%
Book Value / Share
30.96
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NVNO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.000
Upside
+186.40%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

enVVeno Medical Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 30.000
(+186.40% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Ladenburg Thalmann
Buy30.00+186.40%-UpgradeJul 06, 2026

Earnings

Latest Release
Jul 31, 2026
EPS / Forecast
-5.37 / -0.26
Revenue / Forecast
-- / 1M
EPS Revisions
Last 90 days

NVNO Income Statement

Compare NVNO to Peers and Sector

Metrics to compare
NVNO
Peers
Sector
Relationship
P/E Ratio
−0.4x−2.7x−0.4x
PEG Ratio
−0.01−0.310.00
Price/Book
0.3x4.7x2.6x
Price / LTM Sales
-3.1x3.0x
Upside (Analyst Target)
183.0%53.5%56.0%
Fair Value Upside
Unlock0.2%9.1%Unlock

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company’s lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
16.92K2.53%179.30K
Other Institutional Investors
274.37K41.09%2.91M
Public Companies & Retail Investors
376.39K56.37%3.99M
Total
667.67K100.00%7.08M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Perceptive Life Sciences Master Fund, Ltd.7.53%50,258533
Perceptive Advisors LLC7.53%50,258533

People Also Watch

174.10
BWXT
+3.20%
27.43
ADEA
+2.93%
6.7550
LWLG
+4.57%
4.39
IRWD
+3.78%
611.01
STRL
+2.39%

FAQ

What Is the enVVeno Medical (NVNO) Stock Price Today?

The enVVeno Medical stock price today is 10.475 USD.

What Stock Exchange Does enVVeno Medical Trade On?

enVVeno Medical is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for enVVeno Medical?

The stock symbol for enVVeno Medical is "NVNO."

What Is the enVVeno Medical Market Cap?

As of today, enVVeno Medical market cap is 6.990M USD.

What Is enVVeno Medical's Earnings Per Share (TTM)?

The enVVeno Medical EPS (TTM) is -24.899.

When Is the Next enVVeno Medical Earnings Date?

enVVeno Medical will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is NVNO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has enVVeno Medical Stock Split?

enVVeno Medical has split 2 times.

How Many Employees Does enVVeno Medical Have?

enVVeno Medical has 33 employees.

What is the current trading status of enVVeno Medical (NVNO)?

As of Aug 03, 2026, enVVeno Medical (NVNO) is trading at a price of 10.475 USD, with a previous close of 10.600 USD. The stock has fluctuated within a day range of 10.475 USD to 10.700 USD, while its 52-week range spans from 8.670 USD to 179.550 USD.

What Is enVVeno Medical (NVNO) Price Target According to Analysts?

The average 12-month price target for enVVeno Medical is 30.000 USD, with a high estimate of 30 USD and a low estimate of 30 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +186.40% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.